Breastfeeding Advices on OTC Medicines With the Internet: What is the Best Medium
Launched by SEMMELWEIS UNIVERSITY · Mar 6, 2025
Trial Information
Current as of July 23, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is focused on helping breastfeeding mothers in Hungary understand how to safely use over-the-counter (OTC) medications. Many women need to take medicine while breastfeeding, but they may be unsure which ones are safe for their babies. The goal of this study is to create a user-friendly website that provides clear and helpful information about OTC medications, making it easier for mothers to find the guidance they need.
To participate in this trial, you must be a woman over 18 who is either in the 3rd trimester of pregnancy or has recently given birth (within the last week) and plans to breastfeed. You also need to have access to the internet. Participants will help researchers determine the best way to present this important information online. Overall, the study aims to ensure that mothers can make informed decisions about their health and their baby's safety while breastfeeding.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Target population is adult (\>18 years), 3rd trimester pregnant women; and breastfeeding women after childbirth (max. 7 days postpartum; 24:00), who intend to breastfeed.
- • Participants have to have internet access with no regard to the type of internet connection.
- Exclusion Criteria:
- • A mother will not breastfeed, either because they cannot or do not want it.
- • Anyone who do not want to participate in the study.
About Semmelweis University
Semmelweis University, located in Budapest, Hungary, is a prestigious institution renowned for its commitment to advancing medical education, research, and healthcare innovation. As a prominent clinical trial sponsor, the university leverages its extensive expertise in various medical fields to conduct rigorous clinical studies aimed at improving patient outcomes and enhancing therapeutic strategies. With a focus on ethical standards and scientific excellence, Semmelweis University collaborates with a network of healthcare professionals and researchers to translate groundbreaking discoveries into practical applications, ultimately contributing to the global advancement of medical science.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Patients applied
Trial Officials
Dénes Kleiner, PhD
Principal Investigator
Semmelweis University, University Pharmacy Department of Pharmacy Administration
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported